Superior Planning, LLC’s Rhythm Pharmaceuticals RYTM Stock Holding History

Superior Planning, LLC’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.81K	Buy	+40	New	+$4.27K	﹤0.01%	1311

Other funds holding RYTM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Superior Planning, LLC's RYTM Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 40 shares worth $3.81K. The stake represents ﹤0.01% of the portfolio and ranks #1311 among its holdings.

197 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

Superior Planning, LLC held 40 shares of Rhythm Pharmaceuticals worth $3.81K as of Q3 2026.
Rhythm Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1311 holding.
197 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.